H.R. 679 · 119th Congress
To nullify the modifications made by the Food and Drug Administration in January 2023 to the risk evaluation and mitigation strategy for the abortion pill mifepristone, and for other purposes.
- Stage
- In committee
- Sponsor
- Diana Harshbarger
- Introduced
- 2025-01-23
- Latest action
- 2025-01-23 · Introduced in House
Action history
- 2025-01-23Introduced in House
- 2025-01-23Referred to the House Committee on Energy and Commerce.